Covid Treatment Development
Japan-based Shionogi in trials of a pill-based covid treatment, intended to be taken once daily. Merck and Pfizer are already testing similar pill treatments.
Intended for home use to treat mild covid, similar to Tamiflu and similar OTC flu meds.
Current anti-retroviral treatments generally must be administer in a hospital setting.
Details on WSJ (link won't work due to paywall).